The first questions to ask, of course, is who funded the research?

Second, my (fallible) understanding is that Frontiers rejects very few papers. 
Their editors are told to work with authors to improve papers, but they 
ultimately publish nearly all of them. 

Here is one of several pieces that I have read about Frontiers on this issue.
https://forbetterscience.com/2016/08/08/frontiers-reviewer-told-dont-be-strict-endorse-paper-reports-giulia-liberati/
 

I would be interested in knowing more from people who have first-hand knowledge 
of the situation.

Chris
…..
Christopher D Green
Department of Psychology
York University
Toronto, ON M3J 1P3
Canada
43.773895°, -79.503670°

chri...@yorku.ca
http://www.yorku.ca/christo
orcid.org/0000-0002-6027-6709
………………………………...

On Feb 20, 2018, at 9:48 AM, Annette Taylor <tay...@sandiego.edu> wrote:

> 
> 
> 
> 
>  
> So I read this article and here are their results:
> 
> "Sixty-six patients were analyzed as completers (31 EMDR vs. 35 CBT). No 
> significant difference between the two groups was found either at the end of 
> the interventions (71% EMDR vs. 48.7% CBT) or at the 6-month follow-up (54.8% 
> EMDR vs. 42.9% CBT). A RM-ANOVA on BDI-II scores showed similar reductions 
> over time in both groups [F(6,59) = 22.501, p < 0.001] and a significant 
> interaction effect between time and group [F(6,59) = 3.357, p = 0.006], with 
> lower BDI-II scores in the EMDR group at T1 [mean difference = –7.309 (95% CI 
> [–12.811, –1.806]), p = 0.010]. The RM-ANOVA on secondary outcome measures 
> showed similar improvement over time in both groups [F(14,51) = 8.202, p < 
> 0.001], with no significant differences between groups [F(614,51) = 0.642, p 
> = 0.817]. "
> 
> And I would conclude: well the, USE CBT! It is more efficient and cheaper and 
> easier to use since you don't have to ADD a useless add-on to CBT. But 
> NO!!!!!!!!!! here is their conclusion:
> 
> "this study suggests that EMDR could be a viable and effective treatment for 
> reducing depressive symptoms and improving the quality of life of patients 
> with recurrent depression. Trial registration: ISRCTN09958202. "
> 
> WHAT AM I MISSING HERE?  I had a WTF moment here. Sorry if I'm being dense at 
> 6 am. Since tipsters are smart people perhaps you can enlighten me.
> 
> https://www.frontiersin.org/articles/10.3389/fpsyg.2018.00074/full?utm_source=F-AAE&utm_medium=EMLF&utm_campaign=MRK_547424_69_Psycho_20180220_arts_A
> 
> Annette Kujawski Taylor, Ph.D.
> Professor, Psychological Sciences
> University of San Diego
> 5998 Alcala Park
> San Diego, CA 921210
> tay...@sandiego.edu
> 
> 
> ---
> 
> You are currently subscribed to tips as: chri...@yorku.ca.
> 
> To unsubscribe click here: 
> http://fsulist.frostburg.edu/u?id=430248.781165b5ef80a3cd2b14721caf62bd92&n=T&l=tips&o=52141
> 
> (It may be necessary to cut and paste the above URL if the line is broken)
> 
> or send a blank email to 
> leave-52141-430248.781165b5ef80a3cd2b14721caf62b...@fsulist.frostburg.edu
> 
> 
> 
> 
> 


---
You are currently subscribed to tips as: arch...@mail-archive.com.
To unsubscribe click here: 
http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=52142
or send a blank email to 
leave-52142-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu

Reply via email to